Menu
Careers
Contact
Menu
Home
Company
Introduction
Senior Management Team
Board of Directors
Scientific Advisors
Clinical Research
Overview
FAQs
For Patients
Technology
DfuseRx℠ Product Discovery Technology
Pipeline
Lead Product: INT230-6
Mechanism of Action
Intellectual Property and Patents
Partnerships
News & Events
Press Releases
Events and Presentations
Intensity Therapeutics in the News
Publications, Papers and Posters
Investors
Menu
Home
Company
Introduction
Senior Management Team
Board of Directors
Scientific Advisors
Clinical Research
Overview
FAQs
For Patients
Technology
DfuseRx℠ Product Discovery Technology
Pipeline
Lead Product: INT230-6
Mechanism of Action
Intellectual Property and Patents
Partnerships
News & Events
Press Releases
Events and Presentations
Intensity Therapeutics in the News
Publications, Papers and Posters
Investors
Careers
Contact
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
Events & Presentations
Email Alerts
Company Info
Overview
Management Team
Contacts
FAQ
Financials
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Filing Type:
View All
10-K
10-Q
10-Q/A
3
4
424B4
8-A12B
8-A12B/A
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DRS
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13G
SEC STAFF LETTER
UPLOAD
Year:
View All
2024
2023
2022
2021
2015
2014
2013
Date
Form
Description
PDF
XBRL
Pages
11/24/21
FWP
Filing under Securities Act Rules 163/433 of free writing prospectuses
11
11/18/21
S-1/A
General form of registration statement for all companies including face-amount certificate companies
Documents
expand_more
EX-23.1
181
11/12/21
S-1/A
General form of registration statement for all companies including face-amount certificate companies
Documents
expand_more
EX-10.2
EX-10.9
EX-23.1
195
10/28/21
S-1
General form of registration statement for all companies including face-amount certificate companies
Documents
expand_more
EX-3.1
EX-3.3
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-21.1
EX-23.1
247
09/20/21
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
167
06/12/15
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
4
12/02/14
D/A
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
02/11/14
D/A
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
4
01/18/13
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
4
rss_feed
Filing RSS
arrow_back
1…
2
3
4
5
6
7
8
9
10
11
Email Alerts
Contacts
RSS News Feed